U.S. Pharma Stock News

Lineage, Inc. recently announced that its Board of Directors approved a first-quarter 2026 cash dividend of US$0.5325 per share, an annualized US$2.13 per share, representing a 1% increase from the fourth quarter of 2025 and payable on April 21, 2026 to shareholders of record on March 31, 2026. This incremental dividend increase highlights management’s willingness to return more cash to shareholders, which can matter for investors focused on recurring income streams. Next, we’ll examine how...

Edison International (NYSE:EIX) has approved higher executive compensation while facing responsibility for the deadly Eaton wildfire. The company is managing ongoing lawsuits related to the fire, which caused significant loss of life and damage to affected communities. Investors are weighing the pay decisions against legal exposure, reputational risk, and the utility's role in regional power infrastructure. Edison International, the parent of Southern California Edison, is a major regulated...

International General Insurance Holdings Ltd. recently reshaped its Board, adding veteran reinsurance executive Thomas A. Collett and accepting the retirement of long-serving director David D. Anthony, while reallocating key committee roles. The appointment of Collett, with deep U.S. reinsurance market relationships, alongside refreshed committee leadership, may influence IGI’s governance and longer-term business direction. Next, we’ll examine how bringing Thomas A. Collett onto the Board...

Qfin Holdings (NasdaqGS:QFIN) has released its FY 2025 numbers with fourth quarter revenue of C¥4.1b and basic EPS of C¥7.92, setting the stage for investors to reassess how the earnings story lines up with expectations. Over the past six quarters, the company has seen quarterly revenue move between C¥4.1b and C¥5.2b, while basic EPS has ranged from C¥7.92 to C¥13.41, giving you a clear view of how the top line and per share profits have tracked through different trading periods. With...

First Real Estate Investment Trust of New Jersey (FREV.S) opened Q1 2026 with total revenue of US$7.5 million and basic EPS of US$0.13, giving investors a clean read on how the new fiscal year is starting. The company has seen quarterly revenue move in a tight band around US$7.2 million to US$7.5 million since early 2024, while basic EPS has ranged from about US$0.08 to US$0.15 over that stretch. This sets a clear baseline for how earnings power has tracked alongside a largely steady top...

Equifax (NYSE:EFX) released its 2025 Security Annual Report, outlining a major focus on AI-driven cybersecurity in response to rising digital threats. The company is urging shareholders to vote against a proposal that would lower the threshold for investors to call special meetings. Both developments center on risk management and corporate governance, key areas of interest for investors after past security incidents. Equifax operates as a global data, analytics, and technology company, with...

Academy Sports and Outdoors (ASO) has just wrapped up FY 2026 with fourth quarter revenue of US$1,718.5 million, basic EPS of US$2.02 and net income of US$133.7 million, setting a clear benchmark for how the business is currently earning its money. Over recent periods the company has seen quarterly revenue move from US$1,676.9 million in Q4 FY 2025 to US$1,718.5 million in Q4 FY 2026, while basic EPS shifted from US$1.93 to US$2.02 and trailing twelve month net income sat at US$376.8 million...

GitLab's FY 2026 results set the stage for a margins story GitLab (GTLB) closed FY 2026 with fourth quarter revenue of US$260.4 million and a basic EPS loss of US$0.02 per share, alongside trailing twelve month revenue of US$955.2 million and a TTM EPS loss of US$0.34. The company has seen quarterly revenue move from US$196.0 million in Q3 FY 2025 to US$260.4 million in Q4 FY 2026, while quarterly EPS has shifted from a profit of US$0.18 to a loss of US$0.02 over the same stretch, leaving...

If you are wondering whether Primerica's current share price still offers value, the recent mix of returns gives you a useful starting point to question what the market is really pricing in. The stock last closed at US$248.46, with returns of a 1% decline over 7 days, a 1% decline over 30 days, a 4% decline year to date, while still showing gains of 60.3% over 3 years and 87.2% over 5 years. Recent news coverage has focused on Primerica's role as a US insurance provider and distributor of...

Wondering if Manhattan Associates at around US$138 per share still offers value, or if most of the opportunity has already been priced in. The stock is down about 3.6% over the past week, 1.6% over the past month, and 17.4% year to date, with a 20.8% decline over the last year and a 19.5% gain over five years. These moves can change how investors think about both risk and opportunity. Recent coverage has focused on Manhattan Associates as a key player in supply chain and warehouse management...

Williams-Sonoma (WSM) has wrapped up FY 2026 with fourth quarter revenue of US$2.4b and basic EPS of US$3.09, set against a trailing twelve month revenue base of US$7.8b and EPS of US$8.96. Over recent quarters the company has seen revenue move from US$2.5b in Q4 FY 2025 to US$2.4b in Q4 FY 2026, while quarterly EPS shifted from US$3.12 to US$3.09. This is prompting investors to focus on how modest growth expectations line up with a slightly lower trailing net margin and what that may...

SL Green Realty (NYSE:SLG) has agreed to sell the residential and retail components of 7 Dey Street. The company reports that One Madison Avenue is now fully leased. SL Green also highlights significant Manhattan leasing activity so far this year. For investors watching NYSE:SLG, these updates come at a time when the stock trades at $38.37 and has seen very different returns over various time frames, with a 1.5% gain over the past week alongside a 31.8% decline over the past year and a...

Nordic American Tankers (NYSE:NAT) has agreed to sell a 2005 built vessel for around US$40 million. Management describes the transaction as aligned with the company’s current positioning and plans for future fleet growth. The deal affects fleet composition and adds flexibility around capital allocation going forward. The sale comes as Nordic American Tankers trades at a share price of US$5.42, with the stock up 3.4% over the past week and 19.4% over the past month. Returns of 60.8% year to...

Bank7 (BSVN) FY 2025 earnings snapshot Bank7 (BSVN) has wrapped up FY 2025 with fourth quarter revenue of US$24.1 million and basic EPS of US$1.14, while trailing 12 month revenue came in at US$95.7 million and EPS at US$4.56. Over the past six quarters, revenue has ranged between US$22.6 million and US$24.9 million per quarter as EPS moved between US$1.10 and US$1.26. This gives you a clear line of sight on how the top line and per share profits have tracked into the latest print. With a net...

General Mills (GIS) has just posted its Q3 2026 numbers, with revenue at US$4.4b and basic EPS of US$0.57, set against a trailing twelve month EPS of US$4.07 on revenue of US$18.4b. Over recent quarters the company has seen revenue move from US$4.8b in Q2 2026 and US$4.5b in Q1 2026 to the latest US$4.4b print, while basic EPS shifted from US$0.77 and US$2.22 in those periods to US$0.57. This sets up a results season where investors are likely to focus squarely on how margins are holding up...

Insmed (NasdaqGS:INSM) has launched Brinsupri, also known as brensocatib, for non cystic fibrosis bronchiectasis. Brinsupri is the first approved therapy for this condition and has already generated significant initial sales. The successful launch marks a material commercial milestone for Insmed and adds a new revenue stream alongside its existing portfolio. Insmed focuses on treatments for serious and rare respiratory diseases, so the approval and rollout of Brinsupri fit directly into its...

comScore FY 2025 earnings snapshot comScore (SCOR) just closed out FY 2025 with Q4 revenue of US$93.5 million and basic EPS of US$12.77, alongside full year trailing twelve month figures showing revenue of US$357.5 million and a net loss of US$101.8 million. Over recent quarters the company has seen revenue move in a narrow band between US$85.7 million and US$94.9 million per quarter. At the same time, basic EPS has swung from a loss of US$12.79 to a profit of US$12.77. This leaves investors...

Palomar Holdings (NasdaqGS:PLMR) reported strong fourth quarter results, with revenue figures that were materially ahead of earlier analyst expectations. The quarter highlighted performance in the company’s catastrophe insurance focus, an area closely watched by investors given recent weather and loss events. This update reflects current operating momentum for Palomar’s specialty insurance franchise and has not been widely discussed in recent coverage. Palomar focuses on specialty and...

If you are wondering whether Mercury General at around US$87.85 is still offering value or if most of the opportunity has already played out, this overview helps you frame that question clearly. The stock has pulled back with a 0.8% decline over 7 days and a 6.0% decline over 30 days, following very strong returns of 56.5% over 1 year, 216.2% over 3 years and 71.8% over 5 years. Recent attention around the stock has focused on its longer term share price performance and how that compares...

In March 2026, Gambling.com Group reported that fourth-quarter 2025 sales rose to US$46.24 million and full-year 2025 sales reached US$165.45 million, but the company swung to a full-year net loss of US$32.93 million after recording a US$14.01 million impairment on intangible assets. Alongside these results, the company completed a share buyback of 3,960,663 shares for US$35.58 million and issued 2026 revenue guidance of US$170 million to US$180 million, highlighting a growing focus on data...

Protalix BioTherapeutics FY 2025 Earnings Snapshot Protalix BioTherapeutics (PLX) has wrapped up FY 2025 with fourth quarter revenue of US$9.1 million and a basic EPS loss of US$0.07, as investors weigh the latest numbers against the share price of US$2.21. The company has seen quarterly revenue move from US$18.2 million in Q4 2024 to US$10.1 million in Q1 2025, US$15.7 million in Q2 2025, US$17.9 million in Q3 2025 and US$9.1 million in Q4 2025. Basic EPS shifted from US$0.09 in Q4 2024 to...

Yuanbao posted its FY 2025 fourth quarter results with revenue of C¥1.2b and basic EPS of C¥7.49, alongside trailing twelve month EPS of C¥55.72 on revenue of C¥4.4b and net income of C¥2.0b. The company has seen revenue move from C¥888.76m and EPS of C¥11.01 in Q4 2024 to C¥1.2b and C¥7.49 respectively in Q4 2025, set against trailing twelve month earnings growth of 360.7% and an increase in net profit margin from 13.3% to 45.9%. For investors, the latest set of numbers points to a business...

HNI Corporation, NYSE:HNI, is being highlighted as a major participant in the expanding hearth market. The hearth segment is expected to see substantial growth supported by rising demand and new technology. This attention brings fresh focus to HNI’s hearth business, which has not been a recent focus of coverage. HNI, trading at $35.32, is drawing attention for its role in the hearth market at a time when the shares have seen mixed recent returns. The stock shows a 46.3% gain over the past 3...

DocuSign (DOCU) has just wrapped up FY 2026 with fourth quarter revenue of US$836.9 million and basic EPS of US$0.45, alongside net income excluding extra items of US$90.3 million, putting fresh numbers on the table for investors tracking its earnings story. Over recent periods the company has seen quarterly revenue move from US$776.3 million in FY 2025 Q4 to US$836.9 million in FY 2026 Q4, while basic EPS over the same two quarters has gone from US$0.41 to US$0.45, and trailing 12 month EPS...